Items tagged with Drug-resistant TB
Computer model predicts potential impact of short-course therapy against MDR-TB (post)
Johns Hopkins researchers have developed a computer simulation that helps predict under which circumstances a new short-course treatment regimen for drug-resistant tuberculosis could substantially reduce the global incidence and spread of the disease.
Migrant crisis in Europe compounded by MDR-TB (post)
Evidence-based strategies are urgently needed for detecting, preventing and treating multidrug-resistant tuberculosis among migrant populations in low-incidence countries in Europe, according to a narrative review published in Clinical Microbiology and Infection.
China approves Sirturo for MDR-TB (post)
Xian Janssen Pharmaceutical Ltd. announced that the China Food and Drug Administration (CFDA) has approved SIRTURO® (bedaquiline) for use as part of combination therapy in adult patients (18 years and older) with pulmonary multidrug-resistant TB (MDR-TB).
Charity demands Seoul allow TB medication shipment to N. Korea (post)
The nonprofit Eugene Bell Foundation on Thursday (December 22) called on the South Korean Ministry of Unification (MoU) to allow a shipment of multidrug-resistant tuberculosis (MDR-TB) medication to arrive in North Korea as it had promised in August.
Hospital against access to life-saving drug for TB patient as case reaches Delhi High Court (post)
Officials from the National Institute of Tuberculosis and Respiratory Diseases on Monday (January 9) told the Delhi High Court that providing bedaquiline, a life-saving drug, to an 18-year-old woman suffering from a drug-resistant form of TB would fail to treat her. They warned that it may cause the drug-resistant bacteria to spread in her body.
Reducing drug dosage, and hearing loss in TB patients without reducing efficacy (post)
Aminoglycosides, recommended by the World Health Organization to treat multidrug resistant tuberculosis, cause hearing loss and kidney damage in a dose dependent manner. Now, by reducing the dose in a carefully calculated fashion, Dutch clinician researchers have been able to greatly reduce the numbers of patients suffering hearing loss, without compromising effectiveness against tuberculosis. The research was published in Antimicrobial Agents and Chemotherapy, a journal of the American Society for Microbiology.
Delhi hospital agrees to give life-saving drug to TB patient after initial denial (post)
The National Institute of Tuberculosis and Respiratory Diseases on Wednesday (January 18) agreed to administer life-saving drug Bedaquiline to an 18-year-old woman from Patna who suffers from drug-resistant form of TB. “The drug has to be given in combination with other drugs, but doctors at the institute cannot give it to her without first conducting a drug-susceptibility test,” said Saket Sikri, the lawyer representing the institute at the Delhi High Court.
Study provides new evidence on role of person-to person transmission in drug-resistant TB (post)
A study published today in The New England Journal of Medicine provides compelling evidence that extensively drug-resistant tuberculosis (XDR-TB) is spread from person-to-person in the KwaZulu-Natal province, South Africa from 2011-2014. The study was conducted by a team of researchers from Emory University, the U.S. Centers for Disease Control and Prevention, Albert Einstein College of Medicine, and the University of KwaZulu-Natal in South Africa and was funded by the U.S. National Institute of Allergy and Infectious Diseases at the National Institutes of Health. It builds on a growing body of evidence showing that person-to-person transmission, not just inadequate treatment, is driving the spread of drug-resistant TB.
South Korea OKs Eugene Bell Foundation's plan to send TB medication to North Korea (post)
South Korea's Unification Ministry has approved an application by the Eugene Bell Foundation Korea to send medication for tuberculosis to North Korea, a government official said Wednesday (January 18).
Bedaquiline debate: Domicile requirement for TB patients to get live-saving drug may no longer apply (post)
An unreasonable domicile requirement that was responsible for denying the life-saving bedaquiline drug to many patients suffering from drug-resistant tuberculosis may no longer apply.
Page 37 of 117 · Total posts: 0
←First 36 37 38 Last→